Linking electronic medical records and administrative data claims, Truven Health Analytics provides a new oncology-focused data set to help researchers further examine healthcare costs, co-morbidities, adverse events and outcomes for cancer patients, according to a news release.
The MarketScan Oncology EMR-Claims Data Set offers anonymous data for more than 50,000 patients who underwent cancer treatment in the past three years. Such data can help researchers hone in on subpopulations as well as expand their scope to understand the full healthcare continuum, according to the news release.
"As [breakthrough oncology treatments] come to the market, researchers require real-world data to conduct high-quality investigations that demonstrate the value of these new treatments," said Truven Health Analytics vice president and general manager Stacey Long in the news release. "Payers, providers and patients want to understand how new treatments affect not only health outcomes, but also overall costs. To do this, researchers need patient-level data that include not only the robust clinical data offered by an oncology EMR, but also the same patient's claims data to understand associated healthcare costs and the full spectrum of a patient's care beyond that provided by their oncologist."
More Articles on Big Data:
Big Data Analytics Leading the Way to Better Outcomes
Aetna Among Companies Using Claims, EHRs to Predict Chronic Conditions
FDA's Mini-Sentinel Pilot Program Mines Billing Codes to Predict Adverse Drug Events